HER2/neu testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer.
Journal of Clinical Pathology.
Times cited: 59
Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: Results of a randomized clinical trial.
Journal of Clinical Oncology.
Times cited: 20
Incidence and clinical impact of fluoroquinolone-resistant Escherichia coli in the faecal flora of cancer patients treated with high dose chemotherapy and ciprofloxacin prophylaxis.
Journal of Antimicrobial Chemotherapy.
Times cited: 28